Literature DB >> 18061667

Systemic mastocytosis with plasma cell dyscrasia: report of a case.

Sheeja T Pullarkat1, Franklin Sedarat, Ronald Paquette, Jonathan Said.   

Abstract

Systemic mastocytosis (SM) comprises a heterogeneous group of disorders characterized by infiltration of bone marrow and other tissues by neoplastic mast cells. A subset of patients with SM has associated hematologic malignancy usually of myeloid origin and comprises an entity termed systemic mastocytosis with associated clonal hematological non-mast cell lineage disease (SM-AHNMD) by the current WHO classification. Reports of clonal lymphoid malignancies associated with SM are rare. We describe a patient who was simultaneously diagnosed with indolent SM and a plasma cell dyscrasia fitting the definition of monoclonal gammopathy of undetermined significance (MGUS). We also discuss the pathologic interaction between the neoplastic mast cells of SM and the lymphoid/plasma cell malignancy when these two entities coexist.

Entities:  

Mesh:

Year:  2007        PMID: 18061667     DOI: 10.1016/j.leukres.2007.10.017

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  Systemic mastocytosis in association with chronic lymphocytic leukemia and plasma cell myeloma.

Authors:  Shouying Du; Hooman H Rashidi; Dzung T Le; Thomas J Kipps; H Elizabeth Broome; Huan-You Wang
Journal:  Int J Clin Exp Pathol       Date:  2010-04-23

2.  Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications.

Authors:  Håkon Reikvam; Kimberley Joanne Hatfield; Astrid Olsnes Kittang; Randi Hovland; Øystein Bruserud
Journal:  J Biomed Biotechnol       Date:  2011-05-03

3.  Systemic Mastocytosis with Smoldering Multiple Myeloma: Report of a Case.

Authors:  Sassine Ghanem; Gwenalyn Garcia; Liu Ying; Matthew Hurford; Marcel Odaimi
Journal:  Case Rep Oncol Med       Date:  2016-05-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.